- Latest week
- 17 Jul 2026
- Close
- 342.000000
- Fair value
- 351.460487
- Next-week expectancy
- Undecided 52.63%
GUBRA Chart Pack
Gubra A/S
Chart Summary
Over the latest 12 completed weeks ending 2026-07-17, GUBRA rose 6.54%, moving from 321.00 to 342.00. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -20.70 and has improved across the 12-week window. Market Dynamics is 0.42 on the latest week. Next-week expectancy is undecided at 52.63% based on similar historical setup states.
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 342.00
- 12-Week Change
- 6.54%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Undecided 52.63%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Below
- Relative Strength
- -20.70
- Market Dynamics
- 0.42
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 342.00
- 12-Week Change
- 6.54%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Undecided 52.63%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Below
- Relative Strength
- -20.70
- Market Dynamics
- 0.42
Over the latest 12 completed weeks ending 2026-07-17, GUBRA rose 6.54%, moving from 321.00 to 342.00. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -20.70 and has improved across the 12-week window. Market Dynamics is 0.42 on the latest week. Next-week expectancy is undecided at 52.63% based on similar historical setup states.
Industry Peers
Denmark equities in Biotechnology
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| STRAP Strategic Partners A/S | CPH | 17 Jul 2026 | 575.00 | 640.00 | 560.00 | 640.00 | 11.30% |
| PEG Pharma Equity Group A/S | CPH | 17 Jul 2026 | 0.08 | 0.09 | 0.08 | 0.09 | 8.86% |
| ZEAL Zealand Pharma A/S | CPH | 17 Jul 2026 | 282.00 | 304.40 | 268.90 | 295.40 | 4.75% |
| BAVA Bavarian Nordic A/S | CPH | 17 Jul 2026 | 183.10 | 187.50 | 179.50 | 184.10 | 0.55% |
| GMAB Genmab A/S | CPH | 17 Jul 2026 | 1879.50 | 1907.00 | 1840.00 | 1869.00 | -0.56% |
| ALK-B ALK-Abelló A/S | CPH | 17 Jul 2026 | 242.00 | 243.00 | 238.00 | 240.00 | -0.83% |